Literature DB >> 35813780

Bone Changes in Chronic Rhinosinusitis: Pathological or Physiological?

Monika Pokharel1,2, Meera Niranjan Khadilkar1, Suja Sreedharan1, Radha Pai3, Vijendra Shenoy1, Kiran Bhojwani4, Arathi Alva5, Sabah Mohd Zubair6.   

Abstract

Bone remodelling is a normal physiological process which occurs in all bones. Hence bone changes should also be detected in undiseased or minimally diseased ethmoids as well as in chronic rhinosinusitis (CRS) patients. To test this hypothesis, we compared ethmoid bone histology between two groups of patients; a study group of CRS patients and a group of patients whose radiological, endoscopic and symptom scores were significantly less when compared to the CRS group. The study group had 75 patients who underwent functional endoscopic sinus surgery for CRS. The control group included 16 patients who had significantly different endoscopic and radiological scores from the study group. On histopathology, the bone harvested from the ethmoid sinuses were grouped as no remodelling activity (Score 1), mild activity (Score 2) and marked activity (Score 3). Thirty-six percent of patients in the study group and 37.5% of patients in the control group had Score 2 and 3 bone changes and the difference was not statistically significant (χ2 = 1.824, p = 0.402). Correlation of bone changes in CRS done with parameters like Lund-Mackay radiological, surgical and symptom scores and Lund-Kennedy endoscopic scores showed no statistical significance. Similar bone changes were detected in CRS patients and the control group. The bone changes seen in histopathology in CRS patients could partly be due to the normal physiological remodelling occurring in all bones. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  Bone remodelling; Chronic rhinosinusitis; Disease severity; Endoscopy; Ethmoid bone

Year:  2021        PMID: 35813780      PMCID: PMC9256879          DOI: 10.1007/s12070-020-02076-5

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  19 in total

1.  Histopathologic evaluation of the ethmoid bone in chronic sinusitis.

Authors:  R J Giacchi; R A Lebowitz; H T Yee; J P Light; J B Jacobs
Journal:  Am J Rhinol       Date:  2001 May-Jun

2.  Classification and management of rhinosinusitis and its complications.

Authors:  Lana L Jackson; Stilianos E Kountakis
Journal:  Otolaryngol Clin North Am       Date:  2005-12       Impact factor: 3.346

Review 3.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 4.  European position paper on rhinosinusitis and nasal polyps 2007.

Authors:  Wytske Fokkens; Valerie Lund; Joaquim Mullol
Journal:  Rhinol Suppl       Date:  2007

5.  The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study.

Authors:  Jivianne T Lee; David W Kennedy; James N Palmer; Michael Feldman; Alexander G Chiu
Journal:  Am J Rhinol       Date:  2006 May-Jun

6.  Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis.

Authors:  D W Kennedy; B A Senior; F H Gannon; K T Montone; P Hwang; D C Lanza
Journal:  Laryngoscope       Date:  1998-04       Impact factor: 3.325

7.  Staging in rhinosinusitus.

Authors:  V J Lund; I S Mackay
Journal:  Rhinology       Date:  1993-12       Impact factor: 3.681

8.  The impact of osteitis on disease severity measures and quality of life outcomes in chronic rhinosinusitis.

Authors:  Naveen D Bhandarkar; Jess C Mace; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2011 Sep-Oct       Impact factor: 3.858

9.  Bone involvement in chronic rhinosinusitis assessed by 99mTc-MDP bone SPECT.

Authors:  Y J Jang; T W Koo; S Y Chung; S G Park
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-06

Review 10.  Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management.

Authors:  Philippe Eloy; Anne Lise Poirrier; Clotilde De Dorlodot; Thibaut Van Zele; Jean Baptiste Watelet; Bernard Bertrand
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.